1. Home
  2. AXTI vs NEO Comparison

AXTI vs NEO Comparison

Compare AXTI & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AXT Inc

AXTI

AXT Inc

HOLD

Current Price

$32.54

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$8.87

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXTI
NEO
Founded
1986
2001
Country
United States
United States
Employees
N/A
2500
Industry
Semiconductors
Precision Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
1998
2008

Fundamental Metrics

Financial Performance
Metric
AXTI
NEO
Price
$32.54
$8.87
Analyst Decision
Hold
Buy
Analyst Count
3
7
Target Price
$24.50
$11.14
AVG Volume (30 Days)
6.9M
2.0M
Earning Date
05-15-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
35.71
N/A
EPS
N/A
N/A
Revenue
$99,361,000.00
N/A
Revenue This Year
$44.70
$10.63
Revenue Next Year
$42.23
$9.73
P/E Ratio
N/A
N/A
Revenue Growth
31.09
N/A
52 Week Low
$1.13
$4.72
52 Week High
$47.00
$13.74

Technical Indicators

Market Signals
Indicator
AXTI
NEO
Relative Strength Index (RSI) 53.36 26.03
Support Level $2.56 $7.20
Resistance Level N/A $8.89
Average True Range (ATR) 4.95 0.68
MACD 0.23 -0.09
Stochastic Oscillator 42.77 4.21

Price Performance

Historical Comparison
AXTI
NEO

About AXTI AXT Inc

AXT Inc is a developer and producer of compound and single element semiconductor substrates, also known as wafers. The dominant substrates used in producing semiconductor chips and other electronic circuits are made from silicon. It is engaged in the design, development, manufacture, and distribution of high-performance compound semiconductor substrates and the sale of materials. The company provides alternative or specialty materials in the form of substrates or wafers, including compound and single-element substrates. Its compound substrates combine indium with phosphorous or gallium with arsenic. Geographically firm has its business presence across the region of Europe, Japan, Taiwan, China, North America, and the Asia Pacific from which China derives its maximum revenue to the company.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: